Evidence map›Paper›PMID 42012186›Full record

ArticleJournal of virology2026

The oral nucleoside analogue inhibitor VV251 effectively inhibits coinfection by respiratory syncytial virus and influenza A virus.

Ruxue Zhang, Xiaoqin Jian, Yumin Zhang, Yuan Sun, Mengwei Xu, Junyuan Cao, Guanghui Tian, Li Xiang, Jiangshan Shen, Gengfu Xiao and 2 more

Abstract read
In one paragraph

Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ruxue Zhang *State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Center for Biosafety Mega-Science, Wuhan, Hubei, China.ORCID 0000-0002-2518-6185
Xiaoqin Jian *State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Center for Biosafety Mega-Science, Wuhan, Hubei, China.
Yumin ZhangState Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Center for Biosafety Mega-Science, Wuhan, Hubei, China.
Yuan SunState Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Center for Biosafety Mega-Science, Wuhan, Hubei, China.ORCID 0000-0001-8244-7436
Mengwei XuState Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Center for Biosafety Mega-Science, Wuhan, Hubei, China.
Junyuan CaoState Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Center for Biosafety Mega-Science, Wuhan, Hubei, China.
Guanghui TianVigonvita Shanghai Co., Ltd., Shanghai, China.
Li XiangState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Science, Shanghai, China.ORCID 0009-0009-4470-2315
Jiangshan ShenUniversity of Chinese Academy of Sciences, Beijing, China.ORCID 0000-0001-9679-9934
Gengfu XiaoState Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Center for Biosafety Mega-Science, Wuhan, Hubei, China.
Tianwen HuVigonvita Shanghai Co., Ltd., Shanghai, China.
Leike ZhangState Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Center for Biosafety Mega-Science, Wuhan, Hubei, China.ORCID 0000-0002-2593-2571

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) and influenza virus are the principal contributors to respiratory tract infections worldwide. Clinical treatment of RSV or influenza A virus (IAV) is limited and may be postponed because of misdiagnosis or coinfection with multiple pathogens. Here, we described VV251, the prodrug of 4'-fluorouridine, a novel oral nucleoside analog that exhibits potent inhibitory activity against RSV laboratory strains and clinical isolates, as well as IAV,

Indexed as

Antiviral AgentsCoinfectionInfluenza A virusOrthomyxoviridae InfectionsRespiratory Syncytial Virus InfectionsUridineAdministration, OralAnimalsDeoxycytidineDisease Models, AnimalDogsFemaleHumansMadin Darby Canine Kidney CellsMiceMice, Inbred BALB C4'-chloromethyl-2'-deoxy-3',5'-di-O-isobutyryl-2'-fluorocytidineAntiviral AgentsDeoxycytidineUridinecoinfection treatmentinfluenza A virusrespiratory syncytial virusVV251

Identifiers

PMID42012186
PMCPMC13185581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.